DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the DR AGARWALS HEALTH CARE L (AGARWALEYE) share price today?

DR AGARWALS HEALTH CARE L (AGARWALEYE) is trading at ₹485.9 on the NSE, down 1.27% on the day. Source: DocStoX.

What is the PE ratio of DR AGARWALS HEALTH CARE L?

DR AGARWALS HEALTH CARE L has a price-to-earnings (PE) ratio of 115.7 in the Healthcare sector.

What is the market capitalisation of DR AGARWALS HEALTH CARE L?

DR AGARWALS HEALTH CARE L has a market capitalisation of approximately ₹15,492 crore.

DR AGARWALS HEALTH CARE L

AGARWALEYE·NSE·Healthcare

₹485.90▼ -6.25 (-1.27%)

Healthcare · Hospital

Revenue compounding 27% a year

Day₹472.00

₹492.15

52W₹401

₹56851%

Open

₹492.15

High

₹492.15

Low

₹472.00

Prev Close

₹492.15

Volume

89.9K

VWAP

₹482.29

Snapshot

Key fundamentals

Market Cap

₹15,492 Cr

P/E Ratio

115.69Expensive

P/B Ratio

7.46

EPS

₹4.20

Book Value

₹63.90

ROE

6.81%Weak

ROCE

11.00%Decent

Dividend Yield

0.00%

Debt / Equity

0.53Moderate

Face Value

₹1.00

52W High

₹568.00

52W Low

₹401.00

Sector

Healthcare

Industry

Hospital

Avoid

None moatMedium uncertainty

Fair value estimate

₹63

▼ 87.0%downside

Trading at ₹486 — 87% above our estimate

BearFair valueBull

₹54₹63₹78

/100

Business quality — Watch the fundamentals

Growth 85Profitability 21Efficiency 8Valuation 37

Plain English

Our view

Revenue compounding 27% a year
Revenue compounding 27% over 3 years
Weak returns on equity (7%)

Strengths

Revenue compounding 27% over 3 years
Profit growing 18% a year

Risks

Weak returns on equity (7%)
Expensive — trades at 116× earnings
Fundamental red flags (Piotroski 3/9)

How we got there

Fair value methods

Residual income

7% ROE fading to 13% over ~3 yrs, on ₹64 book

₹59

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹78

Analyst target

No analyst coverage

—

Blended fair value₹63

What the numbers say

Investment thesis

Bull case

Revenue compounding 27% over 3 years
Profit growing 18% a year

Bear case

Weak returns on equity (7%)
Expensive — trades at 116× earnings
Fundamental red flags (Piotroski 3/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

115.7Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

6.8%Weak

Above 15% is considered healthy for Indian equities

ROCE

11.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.53Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹15,492 Cr

P/B

7.46

EPS

₹4.20

Div Yield

—

What changed

Recent changes

Domestic institutions-0.1% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 115.7×

Growth

Strong

+27% rev CAGR

Profitability

Modest

6.8% ROE

Financial health

Comfortable

D/E 0.53

Momentum

N/A

No technicals

Today

Trading activity

Delivery %51.0%

Turnover₹433.71L Cr

Trades6,688

VWAP₹482.29

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+26.9%

+34.6%

10Y

—

Profit

+17.7%

—

10Y

—

EPS

—

10Y

—

Profile

Cons

Stock is trading at 7.53 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Company has a low return on equity of 6.11% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Domestic institutions reduced 0.11 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

32%

Promoter

Promoters

32.3%-0.01

Public

2.0%+0.10

FII / FPI

58.0%+0.03

DII

7.7%-0.11

Total shareholders

42,492-1,046 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter32.34%

FII57.97%

DII7.72%

Public1.97%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions